Table 3

 Pretreatment metronidazole sensitivity and eradication of H pylori

Treatment group
LACLAMLCMOAM
Pretreatment metronidazole sensitivity
Intention to treat5-150
 Resistant (%)39 (38.2)41 (37.6)28 (27.2)32 (32.7)
 Sensitive (%)63 (61.8)68 (62.4)75 (72.8)66 (67.3)
Per protocol
 Resistant (%)39 (39.0)39 (38.2)25 (25.5)28 (30.4)
 Sensitive (%)62 (61.0)63 (61.8)73 (74.5)64 (69.6)
Eradication by metronidazole sensitivity
Intention to treat5-150
 Resistant (%)36/39 (92.3)19/41 (46.3)21/28 (75.0)20/32 (62.5)
 (95% CI)(78.0, 98.0)(31.0, 62.4)(54.8, 88.6)(43.7, 78.3)
 Sensitive (%)55/63 (87.3)60/68 (88.2)71/75 (94.7)62/66 (93.9)
 (95% CI)(76.0, 94.0)(77.6, 94.4)(86.2, 98.3)(84.4, 98.0)
Per protocol
 Resistant (%)36/39 (92.3)18/39 (46.2)19/25 (76.0)19/28 (67.9)
 (95% CI)(78.0, 98.0)(30.4, 62.6)(54.5, 89.8)(47.6, 83.4)
 Sensitive (%)54/61 (88.5)57/63 (90.5)69/73 (94.5)60/64 (93.8)
 (95% CI)(77.2, 94.9)(79.8, 96.1)(85.8, 98.2)(84.0, 98.0)
  • 5-150 This is based on those patients in the intention to treat population (n = 496) who had returned for a visit 3 breath test (n = 465) minus those patients (n = 53) who had no pretreatment metronidazole sensitivity reported (n = 412).